SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Orchid Pharma informs about resignation of CS cum CO

14 Dec 2023 Evaluate
Orchid Pharma has informed that Marina Peter has resigned from the position of Company Secretary and Compliance officer of the Company with effect from December 12, 2023. Details as required under regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 read with Part A of Schedule III thereto and SEBI Circular No. SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023, are as enclosed.

The above information is a part of company’s filings submitted to BSE.

Orchid Pharma Share Price

553.00 -2.05 (-0.37%)
22-Apr-2026 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.50
Dr. Reddys Lab 1216.60
Cipla 1239.65
Zydus Lifesciences 928.00
Lupin 2300.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×